INTERPATIENT AND INTRAPATIENT VARIABILITY IN VINBLASTINE PHARMACOKINETICS

被引：40

作者：

RATAIN, MJ ^{[1
]}

VOGELZANG, NJ ^{[1
]}

SINKULE, JA ^{[1
]}

机构：

[1] UNIV CHICAGO,PRITZKER SCH MED,DEPT MED,JOINT SECT HEMATOL ONCOL,CHICAGO,IL 60637

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1987年 / 41卷 / 01期

关键词：

D O I：

10.1038/clpt.1987.9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：61 / 67

页数：7

共 17 条

[1] DETERMINANTS OF SERUM ANTIPYRINE HALF-LIVES IN PATIENTS WITH LIVER-DISEASE [J].

BRANCH, RA ;

HERBERT, CM ;

READ, AE .

GUT, 1973, 14 (07) :569-573

[2]

JACKSON DV, 1984, CANCER CHEMOTH PHARM, V13, P114

[3]

JACKSON V, 1981, CANCER TREAT REP, V65, P1043

[4] THE COMPARATIVE CLINICAL-PHARMACOLOGY AND PHARMACOKINETICS OF VINDESINE, VINCRISTINE, AND VINBLASTINE IN HUMAN PATIENTS WITH CANCER [J].

NELSON, RL .

MEDICAL AND PEDIATRIC ONCOLOGY, 1982, 10 (02) :115-127

[5]

OHNUMA T, 1985, CANCER RES, V45, P464

[6]

POWIS G, 1983, PHARMACOKINETICS ANT, P363

[7] CLINICAL PHARMACOKINETICS OF VINDESINE - REPEATED TREATMENTS BY INTRAVENOUS BOLUS INJECTIONS [J].

RAHMANI, R ;

MARTIN, M ;

FAVRE, R ;

CANO, JP ;

BARBET, J .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (11) :1409-1417

[8]

RAHMANI R, 1985, CANCER TREAT REP, V69, P839

[9]

RATAIN MJ, 1986, CANCER RES, V46, P4827

[10]

ROOT MA, 1975, FED ANAL CHEM SPECTR, P125

← 1 2 →